1219 related articles for article (PubMed ID: 27274225)
1. Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD.
Ji J; von Schéele I; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1035-43. PubMed ID: 27274225
[TBL] [Abstract][Full Text] [Related]
2. The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages.
Lea SR; Reynolds SL; Kaur M; Simpson KD; Hall SR; Hessel EM; Singh D
Int J Chron Obstruct Pulmon Dis; 2018; 13():771-780. PubMed ID: 29535517
[TBL] [Abstract][Full Text] [Related]
3. Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations.
Berenson CS; Kruzel RL; Eberhardt E; Dolnick R; Minderman H; Wallace PK; Sethi S
Thorax; 2014 Sep; 69(9):811-8. PubMed ID: 24686454
[TBL] [Abstract][Full Text] [Related]
4. Budesonide enhances Toll-like receptor 2 expression in activated bronchial epithelial cells.
von Scheele I; Larsson K; Palmberg L
Inhal Toxicol; 2010 May; 22(6):493-9. PubMed ID: 20388003
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients.
Droemann D; Goldmann T; Tiedje T; Zabel P; Dalhoff K; Schaaf B
Respir Res; 2005 Jul; 6(1):68. PubMed ID: 16004610
[TBL] [Abstract][Full Text] [Related]
6. Ceftaroline modulates the innate immune and host defense responses of immunocompetent cells exposed to cigarette smoke.
Bruno A; Cipollina C; Di Vincenzo S; Siena L; Dino P; Di Gaudio F; Gjomarkaj M; Pace E
Toxicol Lett; 2017 Sep; 279():9-15. PubMed ID: 28720485
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Exogenous Factors on Respiratory Pathogen-Induced Innate Alveolar Macrophage Responses in COPD.
Berenson CS; Kruzel RL; Sethi S
Immunol Invest; 2016; 45(2):130-47. PubMed ID: 26853802
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury.
Cairns BA; Barnes CM; Mlot S; Meyer AA; Maile R
J Trauma; 2008 Apr; 64(4):1069-77; discussion 1077-8. PubMed ID: 18404077
[TBL] [Abstract][Full Text] [Related]
9. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
10. IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients.
Xu L; Feng X; Tan W; Gu W; Guo D; Zhang M; Wang F
Arthritis Res Ther; 2013 Oct; 15(5):R170. PubMed ID: 24286242
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.
Southworth T; Metryka A; Lea S; Farrow S; Plumb J; Singh D
Br J Pharmacol; 2012 Aug; 166(7):2070-83. PubMed ID: 22352763
[TBL] [Abstract][Full Text] [Related]
12. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system.
Lendemans S; Kreuzfelder E; Rani M; Bayeeh E; Schade FU; Flohé SB; Waydhas C; Flohé S
J Trauma; 2007 Oct; 63(4):740-6. PubMed ID: 18089999
[TBL] [Abstract][Full Text] [Related]
14. Toll-Like Receptor 2 Release by Macrophages: An Anti-inflammatory Program Induced by Glucocorticoids and Lipopolysaccharide.
Hoppstädter J; Dembek A; Linnenberger R; Dahlem C; Barghash A; Fecher-Trost C; Fuhrmann G; Koch M; Kraegeloh A; Huwer H; Kiemer AK
Front Immunol; 2019; 10():1634. PubMed ID: 31396208
[TBL] [Abstract][Full Text] [Related]
15. TLR4 upregulation underpins airway neutrophilia in smokers with chronic obstructive pulmonary disease and acute respiratory failure.
Pace E; Giarratano A; Ferraro M; Bruno A; Siena L; Mangione S; Johnson M; Gjomarkaj M
Hum Immunol; 2011 Jan; 72(1):54-62. PubMed ID: 20888880
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane suppresses lipopolysaccharide- and Pam3CysSerLys4-mediated inflammation in chronic obstructive pulmonary disease via toll-like receptors.
Zeng X; Liu X; Bao H
FEBS Open Bio; 2021 May; 11(5):1313-1321. PubMed ID: 33590951
[TBL] [Abstract][Full Text] [Related]
17. Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.
Chana KK; Fenwick PS; Nicholson AG; Barnes PJ; Donnelly LE
J Allergy Clin Immunol; 2014 Jan; 133(1):207-16.e1-11. PubMed ID: 24176116
[TBL] [Abstract][Full Text] [Related]
18. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.
Yu M; Wang H; Ding A; Golenbock DT; Latz E; Czura CJ; Fenton MJ; Tracey KJ; Yang H
Shock; 2006 Aug; 26(2):174-9. PubMed ID: 16878026
[TBL] [Abstract][Full Text] [Related]
19. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists.
Chen H; Cowan MJ; Hasday JD; Vogel SN; Medvedev AE
J Immunol; 2007 Nov; 179(9):6097-106. PubMed ID: 17947684
[TBL] [Abstract][Full Text] [Related]
20. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages.
Cabanski M; Steinmüller M; Marsh LM; Surdziel E; Seeger W; Lohmeyer J
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):26-31. PubMed ID: 17690330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
